Abstract Introduction: In spite of introduction of intermediate-acting neuromuscular blocking drugs (NMBDs), incidence of postoperative residual muscle weakness is still high. The aim of this trial is to study the effect of systemic lidocaine infusion on intraoperative consumption of rocuronium and TOF ratios at extubation and on arrival to postanesthesia care unit (PACU). Methods: Forty-six ASA I-III patients aged 16-60 yr were randomly allocated into two groups: lidocaine (L) group (n = 23) and control (C) group (n = 23). After induction of standard endotracheal general anesthesia with fentanyl, propofol and rocuronium, patients of group L were given i.v. lidocaine bolus (1.5 mg kg À1 ) followed by continuous infusion (1.5 mg kg À1 h
Introduction
In spite of introduction of intermediate-acting neuromuscular blocking drugs (NMBDs), incidence of postoperative residual muscle weakness is still high [1] [2] [3] [4] [5] [6] . There is evidence that qualitative monitoring of neuromuscular function does not affect the postoperative train-of-four (TOF) ratios in comparison to relying on clinical signs per se [7] . Surveys of clinical practice in Europe and USA suggest that NMBDs are often administered without proper monitoring [8, 9] . Systemic lidocaine infusion has been used effectively to decrease the requirements of analgesics perioperatively [10] [11] [12] .
However, the effect of systemic lidocaine infusion on intraoperative consumption of NMBDs or TOF ratios at extubation and on arrival to postanesthesia care unit (PACU) was not studied before. The aim of this investigation is to study this effect on one of the intermediate-acting NMBD.
Methods
After Local Ethics Committee approval and patients' informed consent, forty-six ASA I-III patients aged 16-60 yr were enrolled. The enrollment period lasted from September 2011 to March 2012 in King Fahd Military Hospital in Dhahran, KSA. Inclusion criteria included surgeries expected to last more than 1 h with positioning that permits access to a forearm and a hand for neuromuscular monitoring. Exclusion criteria included surgeries that needed moderate to intense muscle paralysis or sudden movement of the patient would induce detrimental effects e.g. intracranial, eye and laparoscopic surgeries and bronchoscopy. Patients with known allergy to amide local anesthetics or seizure activity, those with known or expected difficult airway or body mass index >35 kg m À2 , and those with renal, hepatic or muscle disease (or taking drugs affecting neuromuscular function) were also excluded.
Patients were randomly allocated to two groups using computer-generated codes. These codes were kept in sequentially numbered opaque envelopes. In the morning of surgery, a member of the pharmacy who was not involved in the study opened the allocation envelopes and then prepared either lidocaine 2% or normal saline in ''coded'' 50-ml syringes. Clinical monitoring included electrocardiography, pulse oximetry, noninvasive arterial blood pressure, depth of anesthesia by bispectral index monitor (BIS VISTA, Aspect Medical Systems, Newton, MA USA) and core temperature via an esophageal probe inserted after endotracheal intubation. Intravenous induction was achieved by propofol 2-3 mg kg À1 and fentanyl 100-150 mcg. Endotracheal intubation was facilitated by IV rocuronium 0.6 mg kg À1 (based on lean body weight). Immediately after endotracheal intubation, patients were randomly assigned to receive either lidocaine (group L) or placebo saline (control group C). The syringe contained either lidocaine 2% to be given to patients in group L as a 1.5 mg kg À1 bolus then 1.5 mg kg À1 h À1 infusion or normal saline to be given to patients in group C in equal volumes. Infusion was kept running until endotracheal extubation. The primary anesthesiologist was blinded to the patient's group assignment. Anesthesia was maintained with sevoflurane and 40% oxygen in medical air to maintain BIS from 40 to 60. Lungs were mechanically ventilated to normocarbia as monitored by capnography. Core body temperature was kept in the range of 35.5-37°C and the arm with neuromuscular monitoring >33°C by covering the patients with forced-air mattress (Bair Hugger, Eden Prairie, MN). Intraoperative analgesia was accomplished with intermittent doses of fentanyl 50-100 if blood pressure and heart rate showed sustained elevations (>20% of baseline) for more than 2 min. Neuromuscular blockade was monitored at the adductor pollicis by using acceleromyography (TOF Watch SXÒ, Organon, Inc., Dublin, Ireland). The acceleration transducer was taped to the distal interphalangeal joint of thumb with the study arm being immobilized with a splint. The 2 stimulating electrodes were put on the volar medial side of the forearm over the ulnar nerve just proximal to the wrist crease after cleaning the skin with an alcohol swab. Uncalibrated TOF stimulation (four pulses of 0.2-ms duration at a frequency of 2 Hz) was used. The screen area of the acceleromyography was covered with a sheet of paper to conceal the TOF ratio. Rocuronium was not given based on train-of-four (TOF) count but on one of these clinical signs: 1-any spontaneous movement of the patient 2-dipping in capnography indicating trials of breathing 3-more than 20% increase in peak inspiratory preassure after excluding bronchospasm and mechanical obstruction of the endotracheal tube or breathing circuits 4-sustained increase of blood pressure and heart rate after giving one fentanyl bolus.
The top-up dose of rocuronium given was 5-10 mg. No muscle relaxant was given if the expected time of end of surgery was 20-30 min. During this period, boluses of i.v. propofol 20-40 mg were given if needed. Total cumulative dose of rocuronium and number of top-up doses were recorded.
On conclusion of surgery and a few minutes, sevoflurane was discontinued and all patients were given neostigmine 0.05 mg kg À1 mixed with glycopyrrolate 10 mcg kg À1 if TOF count was P2. Extubation criteria included TOF count of 4 with objective tactile evaluation of absence of fade, obeying simple commands (e.g. eye opening to orders), strong hand grip, adequate regular breathing and adequate areterial oxygenation (SpO 2 > 95%). At that time and immediately before extubation, the sheet of paper was removed from the screen of TOF Watch SXÒ and TOF ratio was measured and recorded. Two consecutive TOF ratios (separated by 15 s) were obtained, and the average of the two values was recorded. If measurements differed by more than 10%, additional TOF ratios were obtained (to four TOF values), and the closest two ratios were averaged. Any event of post-extubation laryngospasm was recorded.
Patients were transferred to postanesthesia care unit (PACU) with oxygen mask during transfer (4-6 L min
À1
). Peripheral oxygen saturation (SpO 2 ) was continually measured in the PACU. An anesthesiologist who was blinded to patients' allocation recorded TOF ratio on arrival (the same way done before extubation). Peripheral oxygen saturation (SpO 2 ) on arrival to PACU was recorded. Any adverse respiratory events (defined as SpO 2 < 95% or airway obstruction requiring intervention i.e. oropharyngeal airway, neck extension, chin lift or jaw thrust) occurring in the PACU was recorded. Number of patients showing mild hypoxemia (SpO2 94-90%) or critical hypoxemia (SpO2 < 90%) were also recorded.
Primary outcome of the study was the TOF ratio at time of tracheal extubation. Murphy et al. [13] found that mean TOF ratio immediately before extubation was 0.67(±0.2).
Assuming that difference of 0.2 in TOF ratio between the groups would be clinically significant, the sample size was calculated to be 21 in each group at alpha error of 0.05 and beta error of 0.1. Twenty-three patients were allocated per group to accommodate for drop-outs.
Secondary outcomes included cumulative doses of rocuronium, number of top-up doses, end-tidal sevoflurane concentrations, TOF count at time of reversal, time from reversal to extubation, intraoperative doses of fentanyl, incidence of postextubation laryngospasm, TOF ratio on arrival to PACU and time the patients were ready to discharge from PACU based on Aldrete score [14] .
Statistical analyses were performed using the SPSS for Windows, version 15 (SPSS Inc., Chicago, IL). Data were first tested for normality by Klomogorov-Smirnov test. Normally distributed continuous data were analyzed by using student t-test. Non-normally distributed continuous and ordinal data were analyzed using Mann-Whitney U test. End-tidal sevoflurane concentrations were analyzed by analysis of variance (ANOVA) test. Categorical data was analyzed by chi square or Fisher's exact test as appropriate. The results are presented as mean ± SD, median (range), or number of patients (percentages) as appropriate. A P value < 0.05 was considered statistically significant.
Results
Seventy-one patients were found eligible for the study. Sixteen patients met the exclusion criteria and 9 patients refused participation. Forty-six patients were randomized to 2 groups: group C (n = 23) and group L (n = 23). No patient was excluded from the study.
There were no significant differences between the two groups as regards to age, gender, weight, height, ASA classification, and surgical procedures ( Table 1) . As depicted in Fig. 1 , end-tidal sevoflurane concentrations were significantly lower in group L than in group P (P < 0.01).
As shown in Table 2 , there were no significant differences between the 2 study groups regarding intraoperative fentanyl doses or core temperature at the end of surgery. The dose of rocuronium and the number of its top-up doses were significantly less in group L than in group C. The time from neostigmine reversal to extubation was significantly longer in group C than group L.
Train-of four ratios were significantly higher in group L than in group C either before extubation or on arrival to PACU ( Table 3) . Number of patients with TOF ratios less than 0.7 or 0.9 was always more in group C than group L either at extubation or on arrival to PACU yet not statistically significant with TOF < 0.7 on arrival to PACU (Table 3) .
Tow patients in group C had post-extubation laryngospasm while no patients in group L had (P = 0.24). However the laryngospasm was partial and treated with applying continuous positive airway pressure. Table 4 shows that PACU hypoxic events were more common in group C than in group L albeit not reaching a statistical significance. Two patients in group C needed oropharyngeal airway insertion to relieve airway obstruction. Patients in group L needed shorter time (min) to be ready for discharge from PACU than control group [49.9(16.3) vs. 56.3(13.3), P = 0.15].
Discussion
The current study shows that intraoperative use of i.v. lidocaine infusion in generally anesthetized patients can result in higher TOF ratios at time of extubation and on arrival to PACU when rocuronium was given based on clinical signs.
Pederson et al. [7] found that intraoperative qualitative monitoring of neuromuscular block did not affect the intraoperative dose of neuromuscular blocking drug (NMBD) nor did it increase the TOF ratios measured in PACU when compared to patients who have received NMBD based on clinical criteria.
However, the authors did not mention exactly what were the clinical criteria they relied on to titrate the NMBD (pancuronium and vecuronium). On the contrary, four clinical signs were predefined to guide the anesthesiologist to titrate rocuronium in the current trial. It was prudent to predefine these clinical signs to decrease the inter-individual variations of NMBD titration among the 9 attending anesthesiologists who supplied anesthesia to patients in this study. Because the operations in which patients' movement or straining could result in catastrophes were excluded, use of NMBD in the current investigation can be described as ''conservative''. This conservative approach may be beneficial in decreasing the incidence of postoperative residual recurarization (PORC) which is still high even with use of intermediate-acting NMBDs [1] [2] [3] [4] [5] [6] . When comparing the mean doses of rocuronium (SD) in all study patients [51.3(7.1)mg] to one recent study by Murphy et al. [15] , it was found that it was nearly 25% less in spite of slight differences in anesthesia durations between the 2 studies. This may be attributed to the different methods guiding the titration of rocuronium in the 2 studies. Murphy et al. [15] used either conventional peripheral nerve stimulator or acceleromyography to guide repeat doses of rocuronium in comparison to the clinical criteria used in the current study. It is clear that reliance on clinical criteria to titrate the NMBDs is not possible in procedures that need deeper levels of muscle relaxation and this can explain the lower doses of rocuronium used because patients undergoing theses procedures were excluded from the study.
Train-of-four ratios were always higher either at extubation time or on arrival to PACU in lidocaine group. Considering TOF ratio less than 0.7 is a critical value at which dangerous respiratory events can occur [16] , 13% of patients in control group had recordings less than this value in comparison to zero percent in lidocaine group. However, this difference does not reach a statistical significance may be because the study was not powered enough to detect that difference. Nevertheless, 35% of patients in control group showed TOF ratios <0.9 on arrival to PACU in comparison to 8% in lidocaine group (P = 0.035). When comparing TOF ratios on arrival to PACU in this study with their counterparts in a recent study by Murphy et al. [17] , it was found that 13% in all study patients had TOF ratios <0.7 compared to 23% in their study and 43% had TOF ratios <0.9 in all study patients compared to 64% in their study. Putting in mind that times of reversal to TOF ratio measurement were relatively comparable in both studies, this difference can be attributed to the conservative clinical guidance of rocuronium titration in the current study in relation to the use of qualitative and quantitative methods of neuromuscular monitoring in their study. In spite of using a quantitative method (acceleromyography) by Murphy et al. [17] in one group, 14.5% of this group arrived to PACU with TOF <0.9 compared to 8% of lidocaine group in the current study.
Cumulative dose of rocuronium used intraoperatively was found to be 15% less in lidocaine group than in control group. It seems that this difference was probably responsible for shorter time of reversal to extubation and the higher TOF ratios in lidocaine group compared to placebo. This difference could not be explained on pharmacokinetic basis because ) to one group and saline to the other group and used rocuronium to facilitate endotracheal intubation. They found no differences between the groups as regards to onset time (to 95% depression of first twitch), total recovery time (TOF ratio 0.9), clinical duration (until first twitch has recovered to 25%), recovery index (time between 25% and 75% recovery of the first twitch) and recovery time (between 25% recovery of the first twitch and TOF ratio 0.9).
The probable explanation of decreased needs of rocuronium in lidocaine group is the ability of lidocaine to blunt the cough airway's reflexes to endotracheal tube. Steinhaus JE and Gaskin L found that lidocaine prevented coughing in 8 from 10 anesthetized patients stimulated by manual displacement of the endotracheal tube [19] . Poulton TJ and James FM III found that lidocaine could significantly decrease the cough responses of awake unmedicated persons [20] . Blunting of airway reflexes was speculated to be the mechanism of this favorable effect. Based on these early studies, investigators have shown that lidocaine could be useful in preventing cough related to endotracheal intubation [21] and extubation [22] .
The dose of lidocaine bolus and infusion used in the study was based on many previous studies that showed that range of 1.5-2 mg kg À1 h À1 did not result in plasma concentration higher than 4 mcg ml À1 [11, 23, 24] which is still below the toxic levels (5 mcg ml) [25] .
Decreased end-tidal concentrations of sevoflurane required to keep BIS between 40 and 60 in lidocaine group may be explained by its inhibitory effects on central nervous system. Systemic local anesthetics reduce minimum alveolar concentration (MAC) of volatile anesthetics in animals by 20-40% [26, 27] . However the study was not powered or designed to detect the effect of lidocaine on MAC.
The results of this study may be encouraging to use lidocaine infusion in general anesthesia to decrease NMBD doses in places lacking quantitative neuromuscular monitors. However one limitation of this study is inappropriateness of this conservative use of NMBD in surgeries that necessitate deep muscle relaxation.
In conclusion, intravenous lidocaine infusion can increase TOF ratios at time of extubation and on arrival to PACU compared to placebo when rocuronium was titrated based solely on clinical criteria.
